Storia in 2 fonti

Fredun Pharmaceuticals Q4 profit rises 56%, announces bonus shares

Fredun Pharmaceuticals reported a 56% rise in Q4 profit, declared a dividend and announced a 2:1 bonus share issue after strong FY26 growth.

Raccontata da

thehindubusinessline.com

economictimes.indiatimes.com

Confronto fonti

2 prospettive sulla stessa storia

AI · summaries

thehindubusinessline.comStai leggendo1 mesi fa

Fredun Pharmaceuticals Q4 profit rises 56%, announces bonus shares

Fredun Pharmaceuticals posted Q4 net profit of ₹11 crore (+56% YoY), with FY26 full-year revenue up 40% to ₹639 crore and EBITDA up 72% to ₹95 crore, alongside a 2:1 bonus share issuance. Margin expansion outpacing revenue growth signals a mix shift toward higher-value segments (nutraceuticals, cosmeceuticals, hormone therapy) — a model worth tracking for pharma stack and contract manufacturing decisions in the Indian generics space.

originale

economictimes.indiatimes.com1 mesi fa

Fredun Pharmaceuticals board approves 2:1 bonus issue

Fredun Pharmaceuticals board has recommended a 2:1 bonus issue, granting two new equity shares for every one held. This decision aims to reward shareholders, reflecting management's confidence in the companys sustained…

Timeline cronologica

lunedì 25 maggio 2026·thehindubusinessline.com
Fredun Pharmaceuticals Q4 profit rises 56%, announces bonus shares
Fredun Pharmaceuticals reported a 56% rise in Q4 profit, declared a dividend and announced a 2:1 bonus share issue after strong FY26 growth.
martedì 26 maggio 2026·economictimes.indiatimes.com
Fredun Pharmaceuticals board approves 2:1 bonus issue
Fredun Pharmaceuticals board has recommended a 2:1 bonus issue, granting two new equity shares for every one held. This decision aims to reward shareholders, reflecting…